F olate, a water-soluble B vitamin, is essential for good health during periods of rapid cell division. Defi ciencies in maternal folate during pregnancy are associated with neural tube defects, the most common of which are spina bifi da and anencephaly. Folate is also necessary for the conversion of homocysteine, and folate defi ciency is associated with cardiovascular risk (1) . Because of the importance of dietary folate, it is imperative to have analytical methods for the quantifi cation of folates in infant formula and adult/pediatric nutritional formula. This method is being submitted as a suitable alternative to conventional microbiological assay methods and HPLC techniques, which, while successful, are relatively complex and time-consuming.
The method, which was single-laboratory validated (SLV; 2), received First Action status as an AOAC Offi cial Method SM under the AOAC Board of Directors-approved alternative pathway (3) . Under this pathway, each method is reviewed by an Expert Review Panel (ERP), and if the method adequately meets standard method performance requirements, it is approved First Action. (Applicable to the determination of folate content in infant formula and adult/pediatric nutritional formula by using optical biosensor assay.) Caution: The method requires the use of chemicals that are irritants, corrosive, and toxic. Consult Material Safety Data Sheets for all substances that are hazardous. Follow all required laboratory safety precautions and wear the proper personal protective equipment. Extraction using toxic substances should be completed under ventilation.
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A. Principle
An automated surface plasmon resonance (SPR) biosensor system with exchangeable carboxymethyldextranfunctionalized chip utilizes folate binding protein (FBP) for the estimation of endogenous reduced folates and supplemental folic acid. Folates are extracted in a reducing buffer and subjected to enzymatic and heat treatments. The extracts are mixed with FBP, and binding to surface-immobilized folic acid is inhibited in an inverse dose-response manner. Detection of FBP binding to the chip is achieved via an SPR optical platform. The resulting binding responses are used to interpolate the concentration of folate in unknown samples by establishing a calibration curve using a four-parameter logistic regression.
B. Apparatus
(a) SPR biosensor instrument.-Capable of using a CM5 sensor chip (Biacore Q, GE Healthcare, Uppsala, Sweden, or equivalent).
(b) Balance.-4 dp.
(c) Automatic pipets.-10-100 μL, 100-1000 μL, and 1-10 mL.
( 
C. Reagents
Note: Refer to adequate manuals or safety data sheets approved by local authorities and ensure that safety guidelines are applied before using chemicals.
( (b) Assay FBP standards.-Intermediate (10 g/mL) and assay (1000 ng/mL) solutions are prepared daily in HBS-EP buffer.
F. Calibration Standard Preparation
(a) Stock standard (100 μg/mL).-Dry approximately 60 mg USP folic acid over phosphorus pentoxide in the dark until constant weight. Accurately weigh 50 mg of the dry folic acid into a 100 mL beaker. Disperse the folic acid in 50 mL water, add 0.1 M sodium hydroxide dropwise until the solution just clears, followed by 1% (v/v) acetic acid dropwise until pH is between 6.9 and 7.2. Wash quantitatively into a 500 mL volumetric fl ask with water, make to 500 mL, and mix well. Aliquot and store at -18°C.
G. Preparation of Test Samples
Perform extraction and analysis using low-level, yellow incandescent light. Dissolve 0.1 g sample in approximately 3 mL extraction buffer. Sonicate 15 min. Heat sample at 100°C for 3 min and cool to room temperature. Add 0.5 mL purifi ed chicken pancreas deconjugase solution. Dilute to 5.0 mL with extraction buffer. Incubate 2 h at 37°C. Heat sample at 100°C for 15 min. Cool to ambient temperature. Remove 1.0 mL aliquot and centrifuge (4500  g, 15 min). Remove supernatant and fi lter through a combined 0.45 and 0.22 μm membrane fi lter. Dilute fi ltrate in extraction buffer to obtain a fi nal folate concentration of 2-6 ng/mL based on expected content.
Note: Dilute nonsupplemented milk products typically from two-to fi ve-fold and supplemented nutritional powders typically from fi ve-to 50-fold with extraction buffer.
H. SPR Analysis Conditions
SPR biosensor assay.-Equilibrate reagents and folic acidimmobilized sensor chips to ambient temperature prior to use.
Dispense calibration standards and sample extracts (150 μL) into the appropriate wells of 96-well microtiter plate and cover with adhesive foil (light protected).
Equilibrate the sensor chip and microfl uidics system with HBS-EP buffer. Position FBP (1000 ng/mL) and regeneration reagent (75 mM sodium hydroxide) in reagent rack appropriately.
Run assay under the following conditions: injection time, 480 s; fl ow rate, 20 μL/min at 25°C.
Perform each analysis cycle under automated instrument control: (1) Mix FBP (1000 ng/mL) with calibrants and sample extracts (1 + 1, v/v). (2) Inject 160 μL over sensor surface. Acquire binding response 30 s after injection relative to initial baseline (10 s before injection).
I. Data Handling
Review all sensograms for any abnormalities, e.g., air spikes, drifting response.
Check for completeness of regeneration of each sample by ensuring that regenerated baseline has returned to initial baseline response.
J. Determination of Folate Standard Curve
Establish a folic acid calibration curve based on a 4-parameter logistic regression and calculate folate content of unknown samples by interpolation:
where response = FBP relative binding response; R hi = response at infi nite folic acid concentration; R lo = response at zero folic acid concentration; A 1 = IC 50 ; A 2 = slope factor; and concentration = folate concentration in extract (ng/mL).
Concentration of folate in sample (μg/100 g):
Folate, μg/100 g = folate (ng/mL)  DF  V  100/W  1/1000 where DF = dilution factor, V = extract volume, and W = sample mass (g).
Reference: J. AOAC Int. 95, in press(2012)
Results and Discussion
The results of the SLV indicate that this method is a suitable routine alternative to methods currently used to determine folate content in milk, and milk-based pediatric and adult nutritional products (2) . According to previously published data, the performance of the method shows an instrumental LOD of 0.1 ng/mL (equivalent to 2.5 μg/100 g for a typical infant formula). The method detection limit is 6.5 μg/100 g with a repeatability and intermediate reproducibility of 3.48 and 4.63% RSD, respectively. Further details regarding the development and validation of the method are as described in Indyk (5) .
The method was adopted by an AOAC ERP using the alternative pathway to First Action status. This method process has been approved by the AOAC Board of Directors. Methods approved under this process will remain First Action for approximately 2 years to allow time to collect additional information and to allow laboratories to use the method and submit any comments regarding the method.
